Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update

FDA approval for EPSOLAY® (benzoyl peroxide, cream, 5%) represents Sol-Gel's second approved product within less than a year; EPSOLAY is patent protected until 2040 Partner Galderma to launch two products in the U.S. this quarter: TWYNEO launched in t